Literature DB >> 17557187

To cut or not to cut: a modeling approach for assessing the role of male circumcision in HIV control.

C N Podder1, O Sharomi, A B Gumel, S Moses.   

Abstract

A recent randomized controlled trial shows a significant reduction in women-to-men transmission of HIV due to male circumcision. Such development calls for a rigorous mathematical study to ascertain the full impact of male circumcision in reducing HIV burden, especially in resource-poor nations where access to anti-retroviral drugs is limited. First of all, this paper presents a compartmental model for the transmission dynamics of HIV in a community where male circumcision is practiced. In addition to having a disease-free equilibrium, which is locally-asymptotically stable whenever a certain epidemiological threshold is less than unity, the model exhibits the phenomenon of backward bifurcation, where the disease-free equilibrium coexists with a stable endemic equilibrium when the threshold is less than unity. The implication of this result is that HIV may persist in the population even when the reproduction threshold is less than unity. Using partial data from South Africa, the study shows that male circumcision at 60% efficacy level can prevent up to 220,000 cases and 8,200 deaths in the country within a year. Further, it is shown that male circumcision can significantly reduce, but not eliminate, HIV burden in a community. However, disease elimination is feasible if male circumcision is combined with other interventions such as ARVs and condom use. It is shown that the combined use of male circumcision and ARVs is more effective in reducing disease burden than the combined use of male circumcision and condoms for a moderate condom compliance rate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17557187     DOI: 10.1007/s11538-007-9226-9

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN: 0092-8240            Impact factor:   1.758


  7 in total

1.  Scaling up circumcision programs in Southern Africa: the potential impact of gender disparities and changes in condom use behaviors on heterosexual HIV transmission.

Authors:  Kyeen M Andersson; Douglas K Owens; A David Paltiel
Journal:  AIDS Behav       Date:  2011-07

2.  Incremental role of male circumcision on a generalised HIV epidemic through its protective effect against other sexually transmitted infections: from efficacy to effectiveness to population-level impact.

Authors:  M-C Boily; K Desai; B Masse; A Gumel
Journal:  Sex Transm Infect       Date:  2008-10       Impact factor: 3.519

3.  Adult male circumcision does not reduce the risk of incident Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis infection: results from a randomized, controlled trial in Kenya.

Authors:  Supriya D Mehta; Stephen Moses; Kawango Agot; Corette Parker; Jeckoniah O Ndinya-Achola; Ian Maclean; Robert C Bailey
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

4.  Modeling the population-level effects of male circumcision as an HIV-preventive measure: a gendered perspective.

Authors:  Jonathan Dushoff; Audrey Patocs; Chyun-Fung Shi
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

5.  Sexual risk compensation following voluntary medical male circumcision: Results from a prospective cohort study amongst human immunodeficiency virus-negative adult men in Botswana.

Authors:  Lisa P Spees; Kathleen E Wirth; Shreshth Mawandia; Semo Bazghina-Werq; Jenny H Ledikwe
Journal:  South Afr J HIV Med       Date:  2020-12-14       Impact factor: 2.744

6.  The cost and impact of male circumcision on HIV/AIDS in Botswana.

Authors:  Lori A Bollinger; John Stover; Godfrey Musuka; Boga Fidzani; Themba Moeti; Lesego Busang
Journal:  J Int AIDS Soc       Date:  2009-05-27       Impact factor: 5.396

Review 7.  Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?

Authors: 
Journal:  PLoS Med       Date:  2009-09-08       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.